In contrast with the ischemia model, miR-139–5p is down-regulated in the cardiac tissue of patients with pressure-overload-induced hypertrophic cardiomyopathy, where its overexpression attenuates cardiomyocyte hypertrophy and expression of HF markers by targeting c-Jun [26]. This evidence concerns the gene JUN and hypertrophic cardiomyopathy.